Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma

Events

Apr 25

Written By Stine Krag Brunvold

In April 2024, Cure SMA hosted a clinical trial update webinar with NMD Pharma.

Check it out here:

Stine Krag Brunvold

NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US